Drugs / Co-amoxiclav
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT05964140 | Dec 2024 → Jun 2027 expected | disorder of facial skeleton | East Lancashire Hospitals NHS Trust | Recruiting | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT04035070 | Jan → Jun 2021 | dental pulp necrosis | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02570347 | May 2016 → Oct 2019 | snakebite envenomation | Jawaharlal Institute of Postgraduate Medical Education & Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03700814 | Jan 2014 → Jun 2015 | tympanic membrane disorder | Tribhuvan University, Nepal | Completed | No outcome recorded |
| Phase 4 | NCT02089568 | Jul 2012 → Aug 2016 | infectious disease | Guy's and St Thomas' NHS Foundation Trust | Completed | No outcome recorded |
| Phase 4 | NCT00156546 | May 2000 → Jul 2006 | urinary tract infection | University of Padova | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02916134 | Sep 2016 → Dec 2019 | appendicitis | Beaumont Hospital | Completed | No outcome recorded |
| — | NCT00355602 | Jul 2006 → Dec 2008 | ulcerative colitis | University of Dundee | Completed | No outcome recorded |
| Comparator or background therapy8 trials | ||||||
| Phase 2 | NCT02517099 Comparator | Jun 2015 → Aug 2018 | asthma | Imperial College London | Completed | No outcome recorded |
| Phase 4 | NCT06804096 Comparator | Feb → Sep 2025 overdue | bacterial pneumonia | Dr. Md. Alimur Reza | Recruiting | No outcome recorded |
| Phase 4 | NCT04563325 Comparator | Sep 2020 → Jan 2024 | bacterial infectious disease, infective arthritis, osteomyelitis | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT02018094 Comparator | Oct 2013 → Mar 2014 | skin infection | Hull University Teaching Hospitals NHS Trust | Completed | No outcome recorded |
| — | NCT04751500 Comparator | Jan 2021 → Nov 2022 | — | Birmingham Women's and Children's NHS Foundation Trust | Completed | No outcome recorded |
| — | NCT03844776 Comparator | Oct 2019 → Dec 2020 | infectious disease | Taibah University | Unknown | No outcome recorded |
| — | NCT04048304 Background | Jul 2019 → Feb 2025 overdue | infectious disease | Balgrist University Hospital | Recruiting | No outcome recorded |
| — | NCT04215770 Comparator | Jan 2018 → Nov 2019 | streptococcal sore throat | Combined Military Hospital, Pakistan | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Co-amoxiclav | “All patients will receive 1 dose of IV antibiotics (co-amoxiclav 1.2g), if no penicillin allergy, on induction of anaesthesia, prior to their surgery.” NCT05964140 ↗15“comparing no prophylaxis with prophylaxis (co-trimoxazole 15 mg/kg per day or co-amoxiclav 15 mg/kg per day) for 12 months.” PMID 18977988 ↗ Nov 2008 “Intravenous co-amoxiclav 1.2g three times daily, then 625mg, orally three times daily.” NCT02916134 ↗ “Co-amoxiclav, vancomycin” NCT04048304 ↗ “Co-amoxiclav” NCT04751500 ↗ |
| Modality | Other / unclassified | “4 weeks of antibiotics targeted to the isolate” NCT02517099 ↗ |
| Route | Intravenous | “single dose of intravenous co-amoxiclav” NCT02089568 ↗ |